Loss of Response to Anti-Tumor Necrosis Factor Alpha Therapy in Crohn's Disease Is Not Associated with Emergence of Novel Inflammatory Pathways.
| Author | |
|---|---|
| Abstract |
:
While monoclonal antibodies against tumor necrosis factor-α (TNFα) are effective in treating Crohn's disease (CD), approximately one-third of patients lose response. The mechanisms underlying this loss of response remain elusive. |
| Year of Publication |
:
2018
|
| Journal |
:
Digestive diseases and sciences
|
| Date Published |
:
2018
|
| ISSN Number |
:
0163-2116
|
| DOI |
:
10.1007/s10620-018-4932-8
|
| Short Title |
:
Dig Dis Sci
|
| Download citation |
